Hepatitis C virus prevalence in Belgium

Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. In Belgium, no recent national population-based hepatitis C virus (HCV) seroprevalence estimate is available. The current study estimat...

Full description

Bibliographic Details
Main Authors: Luk Van Baelen, Johan Van der Heyden, Martin Michaelis
Format: Article
Language:English
Published: Cambridge University Press 2021-01-01
Series:Experimental Results
Subjects:
Online Access:https://www.cambridge.org/core/product/identifier/S2516712X21000204/type/journal_article
_version_ 1811156284170305536
author Luk Van Baelen
Johan Van der Heyden
Martin Michaelis
author_facet Luk Van Baelen
Johan Van der Heyden
Martin Michaelis
author_sort Luk Van Baelen
collection DOAJ
description Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. In Belgium, no recent national population-based hepatitis C virus (HCV) seroprevalence estimate is available. The current study estimated HCV prevalence as part of the first Belgian Health Examination Survey, which was organized in 2018 as a second stage of the sixth Belgian Health Interview Survey. This national population-based cross-sectional study resulted in a weighted national HCV seroprevalence of 0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies.
first_indexed 2024-04-10T04:47:54Z
format Article
id doaj.art-14e62786fe814134afaba6dfb68d9798
institution Directory Open Access Journal
issn 2516-712X
language English
last_indexed 2024-04-10T04:47:54Z
publishDate 2021-01-01
publisher Cambridge University Press
record_format Article
series Experimental Results
spelling doaj.art-14e62786fe814134afaba6dfb68d97982023-03-09T12:34:19ZengCambridge University PressExperimental Results2516-712X2021-01-01210.1017/exp.2021.20Hepatitis C virus prevalence in BelgiumLuk Van Baelen0https://orcid.org/0000-0003-2119-7255Johan Van der Heyden1Martin Michaelis2Department of Epidemiology and public health, Sciensano, Brussels, BelgiumDepartment of Epidemiology and public health, Sciensano, Brussels, BelgiumUniversity of Kent, School of Biosciences, Canterbury, United Kingdom of Great Britain and Northern Ireland, CT2 7NJReliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. In Belgium, no recent national population-based hepatitis C virus (HCV) seroprevalence estimate is available. The current study estimated HCV prevalence as part of the first Belgian Health Examination Survey, which was organized in 2018 as a second stage of the sixth Belgian Health Interview Survey. This national population-based cross-sectional study resulted in a weighted national HCV seroprevalence of 0.02% (95% CI 0.00–0.07%). The results show a much lower HCV seroprevalence compared to previous studies.https://www.cambridge.org/core/product/identifier/S2516712X21000204/type/journal_articleHepatitis Cseroprevalencecross-sectional studypopulation estimateBelgium
spellingShingle Luk Van Baelen
Johan Van der Heyden
Martin Michaelis
Hepatitis C virus prevalence in Belgium
Experimental Results
Hepatitis C
seroprevalence
cross-sectional study
population estimate
Belgium
title Hepatitis C virus prevalence in Belgium
title_full Hepatitis C virus prevalence in Belgium
title_fullStr Hepatitis C virus prevalence in Belgium
title_full_unstemmed Hepatitis C virus prevalence in Belgium
title_short Hepatitis C virus prevalence in Belgium
title_sort hepatitis c virus prevalence in belgium
topic Hepatitis C
seroprevalence
cross-sectional study
population estimate
Belgium
url https://www.cambridge.org/core/product/identifier/S2516712X21000204/type/journal_article
work_keys_str_mv AT lukvanbaelen hepatitiscvirusprevalenceinbelgium
AT johanvanderheyden hepatitiscvirusprevalenceinbelgium
AT martinmichaelis hepatitiscvirusprevalenceinbelgium